Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th November 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues product defect alert
The recall affects the 400mg/ml containers of batch 20K091 with the expiry date of October 2022.
Recall affects batch of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

The Veterinary Medicines Directorate (VMD) has issued a product defect alert for a single batch of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

The recall affects the 400mg/ml containers of batch 20K091 with the expiry date of October 2022.

The VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Eurovet Animal Health BV has initiated a Class II recall of Revozyn RTU 400 mg/ml Suspension for Injection for Cattle.

‘This recall is due to confirmed out of specification particle size distribution (the percentage of particles greater than 50 µm exceeds the specification) and out of specification redispersion time.’

The manufacturer, Eurovet Animal Health BV, is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.